Patent · US Active

Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof

US9114108B2 · kind B2 · utility

5Cited by
7References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2012
Grant dateAug 25, 2015
Priority date
Expiry dateFeb 17, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides recombinant herpesvirus of turkeys (HVT) vectors that contain and express antigens of avian pathogens, compositions comprising the recombinant HVT vectors, polyvalent vaccines comprising the recombinant HVT vectors and one or more wild type viruses or recombinant vectors. The present invention further provides methods of vaccination against a variety of avian pathogens and method of producing the recombinant HVT vectors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.